© 1996 Oxford University Press
research-article |
Subchronic Toxicity of 4-Vinylcyclohexene in Rats and Mice by Inhalation Exposure
*Exxon Biomedical Sciences, Inc East Millstone, New Jersey 08875
Haskell Laboratories. DuPont Newark, Delaware 19714
Consulting Services Langhorne, Pennsylvania 19047
Union Carbide Corporation Danbury, Connecticut 06817
¶Chemical Manufacturers Association Washington DC 20037
Received September 6, 1995; accepted January 30, 1996
This study was conducted to evaluate the subchronic toxicity of 4-vinylcyclohexene (VCH). Male and female Sprague–Dawley rats and B6C3F1 mice were exposed by inhalation to VCH 6 hr/ day, 5 days/week for 13 weeks. Rats were exposed to 0, 250, 1000, or 1500 ppm, and mice were exposed to 0, 50, 250, or 1000 ppm. In addition, another group of rats and mice was exposed to 1000 ppm butadiene so that a comparison could be made between the two compounds. Exposure to 1000 ppm VCH resulted in deaths of all male mice and 5/10 female mice on Test Days 11 or 12. Three additional female mice exposed to 1000 ppm VCH died prior to study completion. The most notable compound-related clinical sign was lethargy observed in the 1500 ppm VCH-exposed rats and 1000 ppm VCH-exposed mice. Male rats exposed to 1500 ppm VCH had significantly lower body weights compared to controls, and male and female rats in the 1500 ppm group had signifi cantly lower body weight gains. None of the VCH-exposed animals or butadiene-exposed rats showed any compound-related hemato logical effects. However, mice exposed to 1000 ppm butadiene exhibited mild macrocytic anemia. Clinical chemistry evaluation and urinalysis showed no compound-related effects in rats exposed to either VCH or butadiene. Male and female rats exposed to 1000 or 1500 ppm VCH or 1000 ppm butadiene had increased absolute and/or relative liver weights, and male rats in these same exposure groups had increased relative kidney weights. Microscopically, in creased accumulation of hyaline droplets was observed in the kid neys of male rats from all VCH exposure groups. Although compound–related, the droplets were not accompanied by cytotoxicity. In mice, the most notable adverse histopathological effect was ovarian atrophy in females exposed to 1000 ppm VCH or 1000 ppm butadiene. The atrophy was slightly more severe in the VCH exposed females than in the butadiene–exposed females. There were no other compound–related pathological effects in male or female mice exposed to VCH. Additionally, butadiene–exposed male mice had decreased testicular weights, accompanied by slight testicular degeneration and atrophy. For VCH exposure, the no–observed-adverse–effect–level is 1000 ppm for rats based on leth argy and lowered body weights and 250 ppm for mice based on mortality and ovarian atrophy.